Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

JAK2 V617F clonal disorders: fate or chance?

Blood - 25 Aug 2016

Vassiliou George S

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cells, Cultured
Share to JAK2 gene
Share to Janus Kinase 2
Share to Mutation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Myeloproliferative Disorders

Source

Open in PubMed Open full text

Identifiers

PMID: 27563148
DOI: 10.1182/blood-2016-07-726448
PMCID: PMC5305049

Genes

JAK2

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

JAK2 V617F clonal disorders: fate or chance?PMID 27563148Read ↗

JAK2V617F: more than a clonal marker?Semantic proximity Read ↗

JAK2 V617F: a single mutation in the myeloproliferative group of disorders.Semantic proximity Read ↗

A JAK2 mutation in myeloproliferative disorders: pathogenesis and therapeutic and scientific prospectsSemantic proximity Read ↗

<i>JAK2</i>Mutations in Myeloproliferative DisordersSemantic proximity Read ↗

JAK2 mutations other than V617F: a novel mutation and mini review.Semantic proximity Read ↗

BCR-ABL1-positive and JAK2 V617F-positive clones in 23 patients with both aberrations reveal biologic and clinical importance.Semantic proximity Read ↗

The saga of JAK2 mutations and translocations in hematologic disorders: pathogenesis, diagnostic and therapeutic prospects, and revised World Health Organization diagnostic criteria for myeloproliferative neoplasmsSemantic proximity Read ↗

Clinical and biological characterization of patients with low (0.1-2%) JAK2V617F allele burden at diagnosisSemantic proximity Read ↗

Clinical relevance of JAK2 (V617F) mutant allele burden.Semantic proximity Read ↗

JAK2: implications for diagnosis and classification of myeloproliferative disorders.Semantic proximity Read ↗

Somatic JAK2 mutations and their tumor phenotypes.Semantic proximity Read ↗

Prevalance of JAK2 V617F and exon 12 mutations in polycythaemia veraSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.